SARS-CoV-2 seroprevalence among vaccinated nursing home residents and staff in Belgium in August 2021

The SCOPE study assesses the prevalence of anti-SARS-CoV-2 antibodies among a representative sample of residents and staff in Belgian NH (nursing homes). Starting from February 1st 2021, a cohort of 1,640 residents and 1.368 staff members in 69 Belgian NHs are being tested every two months on the presence of anti-SARS-CoV-2 antibodies. This brief communication reports on the prevalence of anti-SARS-CoV-2 antibodies among vaccinated nursing home residents and staff. At the end of April 2021, the large scale vaccination campaign in Belgian nursing homes, which took place between January 5th and... Mehr ...